X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2611) 2611
Publication (190) 190
Book Review (17) 17
Magazine Article (9) 9
Book Chapter (7) 7
Book / eBook (6) 6
Newsletter (2) 2
Conference Proceeding (1) 1
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2301) 2301
male (1335) 1335
female (1190) 1190
middle aged (844) 844
index medicus (833) 833
adult (763) 763
enterobacteriaceae infections - complications (682) 682
aged (627) 627
enterobacteriaceae (552) 552
enterobacteriaceae infections - microbiology (515) 515
anti-bacterial agents - therapeutic use (501) 501
infectious diseases (497) 497
enterobacteriaceae infections - drug therapy (469) 469
enterobacteriaceae - isolation & purification (426) 426
microbiology (395) 395
infections (330) 330
adolescent (323) 323
enterobacteriaceae infections - etiology (315) 315
risk factors (315) 315
enterobacteriaceae infections - diagnosis (282) 282
child (275) 275
animals (265) 265
infant (263) 263
bacteria (236) 236
infant, newborn (236) 236
microbial sensitivity tests (229) 229
anti-bacterial agents - pharmacology (215) 215
enterobacteriaceae - drug effects (212) 212
research (212) 212
retrospective studies (210) 210
bacteremia (208) 208
antibiotics (207) 207
child, preschool (205) 205
health aspects (203) 203
enterobacteriaceae infections - epidemiology (193) 193
epidemiology (188) 188
treatment outcome (187) 187
research article (185) 185
aged, 80 and over (184) 184
mortality (183) 183
escherichia-coli (181) 181
infection (174) 174
immunology (172) 172
surgery (171) 171
enterobacter (161) 161
bacteremia - microbiology (160) 160
complications and side effects (160) 160
medicine, general & internal (146) 146
enterobacteriaceae infections (142) 142
klebsiella-pneumoniae (141) 141
pediatrics (141) 141
pharmacology & pharmacy (139) 139
risk-factors (136) 136
medicine (132) 132
sepsis (131) 131
prevalence (128) 128
drug resistance (127) 127
prospective studies (127) 127
drug resistance in microorganisms (126) 126
pregnancy (125) 125
sepsis - etiology (124) 124
drug resistance, multiple, bacterial (122) 122
care and treatment (116) 116
pathogens (114) 114
escherichia coli - isolation & purification (111) 111
cross infection - microbiology (110) 110
analysis (106) 106
patients (106) 106
mice (105) 105
urinary tract infections - microbiology (104) 104
diagnosis (103) 103
drug resistance, bacterial (103) 103
drug resistance, microbial (103) 103
hospitals (103) 103
resistance (103) 103
acute disease (102) 102
urinary tract infections - drug therapy (102) 102
sepsis - microbiology (101) 101
bacterial infections (100) 100
e coli (99) 99
sepsis - complications (98) 98
time factors (98) 98
young adult (95) 95
escherichia coli (94) 94
bacteremia - drug therapy (90) 90
children (90) 90
feces - microbiology (90) 90
beta-lactamases - genetics (89) 89
enterobacter cloacae (86) 86
enterobacteriaceae infections - pathology (86) 86
enterobacteriaceae infections - therapy (86) 86
cross infection - epidemiology (85) 85
tomography, x-ray computed (84) 84
antimicrobial agents (82) 82
antimicrobial resistance (82) 82
beta-lactamases - metabolism (82) 82
urinary tract infections (82) 82
blood-stream infections (81) 81
gram-negative bacteria (81) 81
anti-bacterial agents - administration & dosage (80) 80
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2174) 2174
French (112) 112
Spanish (110) 110
Russian (80) 80
German (61) 61
Polish (27) 27
Japanese (21) 21
Italian (20) 20
Romanian (8) 8
Chinese (7) 7
Portuguese (5) 5
Turkish (3) 3
Czech (2) 2
Dutch (2) 2
Hungarian (1) 1
Persian (1) 1
Serbian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Emerging Infectious Diseases, ISSN 1080-6040, 2008, Volume 14, Issue 1, pp. 143 - 148
During 1997-2004, microbiologically confirmed gastrointestinal infections were reported for 101,855 patients in Sweden. Among patients who had Salmonella... 
INFECTIOUS DISEASES | ENTEROHEMORRHAGIC ESCHERICHIA-COLI | DIARRHEA | INCREASED RISK | GUILLAIN-BARRE-SYNDROME | NONTYPHOID SALMONELLA BACTEREMIA | SURVEILLANCE | CAMPYLOBACTER INFECTION | IMMUNOLOGY | ARTHRITIS | GASTROENTERITIS | IRRITABLE-BOWEL-SYNDROME | Campylobacter Infections - complications | Gastroenteritis - epidemiology | Follow-Up Studies | Humans | Middle Aged | Child, Preschool | Gastroenteritis - microbiology | Infant | Male | Time | Colitis, Ulcerative - epidemiology | Incidence | Salmonella Infections - epidemiology | Yersinia Infections - complications | Aged, 80 and over | Adult | Female | Child | Infant, Newborn | Yersinia Infections - epidemiology | Colitis, Ulcerative - complications | Salmonella Infections - complications | Gastroenteritis - complications | Arthritis, Reactive - epidemiology | Sweden - epidemiology | Aortic Aneurysm - complications | Colitis, Ulcerative - microbiology | Adolescent | Aged | Campylobacter Infections - epidemiology | Causes of | Complications and side effects | Bacterial infections | Gastrointestinal diseases | epidemiology | numerical data | hospitalization | Gastroenteritis | enterobacteriaceae infections | risk | Research | campylobacter infections | registries | statistics | Medical and Health Sciences | Aortic Aneurysm/complications | Arthritis; Reactive/epidemiology | Medicin och hälsovetenskap | Salmonella Infections/complications/epidemiology | Infant; Newborn | Aged; 80 and over | Child; Preschool | Yersinia Infections/complications/epidemiology | Campylobacter Infections/complications/epidemiology | Gastroenteritis/complications/epidemiology/microbiology | Colitis; Ulcerative/complications/epidemiology/microbiology | Sweden/epidemiology
Journal Article
European Journal of Clinical Investigation, ISSN 0014-2972, 08/2015, Volume 45, Issue 8, pp. 824 - 832
Background Catheter‐related bloodstream infections (CRBSIs) are currently detected in patients with clinically suspicion. The aim of our study was to evaluate... 
haematooncology | screening | catheter‐related blood stream infection | peptide nucleic acid fluorescence in situ hybridization | Acridine orange leucocyte cytospin | Peptide nucleic acid fluorescence in situ hybridization | Screening | Catheter-related blood stream infection | Haematooncology | MEDICINE, RESEARCH & EXPERIMENTAL | DIAGNOSIS | MANAGEMENT | GUIDELINES | PREVENTION | SOCIETY | MEDICINE, GENERAL & INTERNAL | ONCOLOGY | peptide nucleic acid fluorescence insitu hybridization | BACTEREMIA | POSITIVITY | HEMATOLOGY | catheter-related blood stream infection | CULTURES | Enterobacteriaceae Infections - diagnosis | Fungemia - complications | Humans | Middle Aged | Male | Staphylococcal Infections - complications | Candidiasis - diagnosis | Enterobacteriaceae Infections - complications | Peptide Nucleic Acids | Adult | Female | Catheter-Related Infections - diagnosis | Hematologic Neoplasms - complications | Gram-Positive Bacterial Infections - complications | Stenotrophomonas maltophilia | Escherichia coli Infections - diagnosis | Central Venous Catheters | Bacteremia - complications | False Negative Reactions | Gram-Negative Bacterial Infections - complications | Pseudomonas Infections - complications | In Situ Hybridization, Fluorescence | Pseudomonas Infections - diagnosis | Bacteremia - diagnosis | Gram-Positive Bacterial Infections - diagnosis | Klebsiella Infections - complications | Fungemia - diagnosis | Candidiasis - complications | Staphylococcal Infections - diagnosis | Acridine Orange | Klebsiella Infections - diagnosis | Aged | Gram-Negative Bacterial Infections - diagnosis | Catheter-Related Infections - complications | Escherichia coli Infections - complications | Fluorescent Dyes | Cohort Studies
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2017, Volume 61, Issue 4
Based upon knowledge of the hydrolytic profile of major-beta-lactamases found in Gram-negative bacteria, we tested the efficacy of the combination of... 
Metallo-β-lactamases | Avibactam | Disk diffusion | Ceftazidime | Aztreonam | GRAM-NEGATIVE INFECTIONS | ceftazidime | aztreonam | avibactam | PENICILLIN-BINDING PROTEINS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | TIME | disk diffusion | INHIBITORS | metallo-beta-lactamases | KLEBSIELLA-PNEUMONIAE | Azabicyclo Compounds - pharmacology | Enterobacteriaceae - enzymology | Klebsiella pneumoniae - drug effects | Ceftazidime - pharmacology | Humans | Aztreonam - pharmacology | Colony Count, Microbial | Microbial Sensitivity Tests | Neutropenia - complications | beta-Lactamases - genetics | Neutropenia - microbiology | Klebsiella pneumoniae - genetics | Female | Soft Tissue Infections - drug therapy | beta-Lactamases - metabolism | Drug Therapy, Combination | Neutropenia - chemically induced | Enterobacteriaceae - growth & development | Gene Expression | Klebsiella Infections - drug therapy | Drug Administration Schedule | Enterobacteriaceae Infections - microbiology | Thigh | Enterobacteriaceae - genetics | Klebsiella Infections - complications | Klebsiella Infections - microbiology | Plasmids - metabolism | Neutropenia - drug therapy | Soft Tissue Infections - complications | Cyclophosphamide | Animals | Soft Tissue Infections - microbiology | Enterobacteriaceae - drug effects | Klebsiella pneumoniae - enzymology | Plasmids - chemistry | Klebsiella pneumoniae - growth & development | Anti-Bacterial Agents - pharmacology | Mice | beta-Lactam Resistance - genetics | Enterobacteriaceae Infections - drug therapy | beta-Lactam Resistance - drug effects
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 09/2016, Volume 63, Issue 6, pp. 754 - 762
Journal Article
Infection control and hospital epidemiology, ISSN 0899-823X, 08/2015, Volume 36, Issue 8, pp. 981 - 985
Journal Article
Colorectal Disease, ISSN 1462-8910, 12/2013, Volume 15, Issue 12, pp. 1529 - 1536
Aim The object of this study was to describe the course of Fournier's gangrene and assess quality of life in a group of affected patients. Method We evaluated... 
short‐form‐36 | Fournier's gangrene | quality of life | sepsis | necrotizing fasciitis | Sepsis | Short-form-36 | Necrotizing fasciitis | Quality of life | short-form-36 | GASTROENTEROLOGY & HEPATOLOGY | Follow-Up Studies | Humans | Middle Aged | Fasciitis, Necrotizing - psychology | Fasciitis, Necrotizing - therapy | Male | Fournier Gangrene - psychology | Enterobacteriaceae Infections - therapy | Staphylococcal Infections - complications | Coinfection - complications | Enterobacteriaceae Infections - complications | Coinfection - therapy | Genital Diseases, Female - therapy | Anti-Bacterial Agents - therapeutic use | Sexual Dysfunction, Physiological - psychology | Genital Diseases, Female - psychology | Fasciitis, Necrotizing - complications | Aged, 80 and over | Bacteroidaceae Infections - therapy | Adult | Female | Retrospective Studies | Enterobacteriaceae Infections - psychology | Length of Stay | Bacteroidaceae Infections - psychology | Bacteroidaceae Infections - complications | Fournier Gangrene - therapy | Pseudomonas Infections - psychology | Streptococcal Infections - therapy | Staphylococcal Infections - psychology | Pseudomonas Infections - therapy | Pseudomonas Infections - complications | Treatment Outcome | Genital Diseases, Female - complications | Fournier Gangrene - complications | Staphylococcal Infections - therapy | Debridement | Coinfection - psychology | Sexual Dysfunction, Physiological - etiology | Quality of Life | Aged | Streptococcal Infections - complications | Streptococcal Infections - psychology | Gangrene
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 09/2012, Volume 176, Issue 5, pp. 387 - 395
In developing countries where diarrheal disease is a leading cause of morbidity and mortality in children under 5 years of age, enteric coinfection is common.... 
prevalence | Escherichia coli | rotavirus | interaction | synergism | Giardia | diarrhea | case-control studies | CHILDHOOD DIARRHEA | ENTERIC PATHOGENS | ACUTE GASTROENTERITIS | ESCHERICHIA-COLI | CHILDREN | ENHANCES INVASIVENESS | INFECTIOUS-DISEASE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ENTEROCYTE-LIKE CELLS | ELECTROLYTE TRANSPORT | GIARDIA-LAMBLIA | Rotavirus Infections - complications | Prevalence | Humans | Virulence | Giardiasis - epidemiology | Child, Preschool | Diarrhea - epidemiology | Infant | Rotavirus Infections - diagnosis | Giardia - pathogenicity | Case-Control Studies | Coinfection - complications | Young Adult | Diarrhea - microbiology | Escherichia coli - pathogenicity | Adult | Rotavirus - isolation & purification | Odds Ratio | Child | Infant, Newborn | Escherichia coli Infections - diagnosis | Giardiasis - complications | Rotavirus - pathogenicity | Rotavirus Infections - epidemiology | Coinfection - epidemiology | Ecuador - epidemiology | Giardia - isolation & purification | Escherichia coli Infections - epidemiology | Escherichia coli - isolation & purification | Adolescent | Giardiasis - diagnosis | Coinfection - diagnosis | Escherichia coli Infections - complications | Prevention | Complications and side effects | Enterobacteriaceae infections | Demographic aspects | Comorbidity | Research | Viral diarrhea | Risk factors | Original Contributions
Journal Article
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, ISSN 0066-4804, 08/2017, Volume 61, Issue 8
Journal Article
Auris Nasus Larynx, ISSN 0385-8146, 2017, Volume 45, Issue 2, pp. 362 - 366
Abstract We herein present three cases of abnormally expanded frontal sinuses (pneumoceles) with severe infection in patients with mental retardation and brain... 
Otolaryngology | Endoscopic sinus surgery | Mental retardation | Pneumocele | Sinusitis | Brain atrophy | Frontal sinus | OTORHINOLARYNGOLOGY | PNEUMOSINUS-DILATANS | MULTIPLEX | Frontal Sinusitis - complications | Frontal Sinusitis - diagnostic imaging | Brain - diagnostic imaging | Moraxella (Branhamella) catarrhalis | Orbital Cellulitis - surgery | Humans | Moraxellaceae Infections - diagnostic imaging | Intellectual Disability - complications | Male | Tomography, X-Ray Computed | Enterobacteriaceae Infections - diagnostic imaging | Abscess - complications | Moraxellaceae Infections - complications | Abscess - diagnostic imaging | Enterobacteriaceae Infections - complications | Pseudomonas Infections - surgery | Atrophy | Young Adult | Paranasal Sinus Diseases - diagnostic imaging | Abscess - surgery | Frontal Sinus - surgery | Adult | Female | Pseudomonas aeruginosa | Subcutaneous Tissue | Enterobacteriaceae Infections - surgery | Orbital Cellulitis - complications | Paranasal Sinus Diseases - complications | Endoscopy | Acinetobacter Infections - complications | Orbital Cellulitis - diagnostic imaging | Pseudomonas Infections - complications | Acinetobacter Infections - diagnostic imaging | Pseudomonas Infections - diagnostic imaging | Frontal Sinus - diagnostic imaging | Fever | Acinetobacter baumannii | Acinetobacter Infections - surgery | Frontal Sinusitis - surgery | Surgery, Computer-Assisted | Brain - pathology | Paranasal Sinus Diseases - surgery | Aged | Citrobacter koseri | Moraxellaceae Infections - surgery
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2015, Volume 59, Issue 12, pp. 7558 - 7563
A new category of cefepime susceptibility, susceptible dose dependent (SDD), for Enterobacteriaceae, has been suggested to maximize its clinical use. However,... 
AMPC BETA-LACTAMASE | GRAM-NEGATIVE BACTEREMIA | EXTENDED-SPECTRUM | ESCHERICHIA-COLI | RESISTANCE | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | CEPHALOSPORINS | INHIBITORS | BLOOD-STREAM INFECTIONS | Multivariate Analysis | Diabetes Complications | Humans | Middle Aged | Renal Insufficiency, Chronic - microbiology | Bacteremia - mortality | Male | Renal Insufficiency, Chronic - complications | Enterobacteriaceae Infections - complications | Renal Insufficiency, Chronic - drug therapy | Bacteremia - microbiology | Cephalosporins - therapeutic use | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Neoplasms - complications | beta-Lactamases - genetics | Renal Insufficiency, Chronic - mortality | Female | Retrospective Studies | beta-Lactamases - metabolism | Diabetes Mellitus - mortality | Severity of Illness Index | Enterobacter cloacae - drug effects | Enterobacter cloacae - genetics | Gene Expression | Enterobacter cloacae - metabolism | Enterobacteriaceae Infections - microbiology | Neoplasms - microbiology | Bacteremia - complications | Bacteremia - drug therapy | Diabetes Mellitus - drug therapy | Enterobacteriaceae Infections - mortality | Neoplasms - mortality | Treatment Outcome | Diabetes Mellitus - microbiology | Neoplasms - drug therapy | Carbapenems - therapeutic use | Survival Analysis | Aged | beta-Lactam Resistance - genetics | Enterobacteriaceae Infections - drug therapy | Clinical Therapeutics
Journal Article
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2017, Volume 61, Issue 4
A total of 521 unique clinical isolates from cancer patients with primarily (> 90%) bloodstream infections were tested for susceptibility to... 
Clinical isolates | Avibactam | Cancer patients | Ceftazidime | ORGANISMS | URINARY-TRACT-INFECTIONS | GRAM-NEGATIVE INFECTIONS | ceftazidime | NEUTROPENIA | avibactam | cancer patients | RESISTANCE | LACTAMASE INHIBITOR | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | clinical isolates | Azabicyclo Compounds - pharmacology | Pseudomonas aeruginosa - isolation & purification | Ceftazidime - pharmacology | Humans | Pseudomonas aeruginosa - growth & development | Enterobacteriaceae - isolation & purification | Enterobacteriaceae Infections - complications | Microbial Sensitivity Tests | Neoplasms - complications | Piperacillin - pharmacology | Drug Resistance, Multiple, Bacterial | Cephalosporins - pharmacology | Enterobacteriaceae - growth & development | Penicillanic Acid - analogs & derivatives | Opportunistic Infections - complications | Penicillanic Acid - pharmacology | Pseudomonas Infections - drug therapy | Enterobacteriaceae Infections - microbiology | Neoplasms - microbiology | Pseudomonas Infections - complications | Pseudomonas aeruginosa - drug effects | Thienamycins - pharmacology | Pseudomonas Infections - microbiology | Neoplasms - drug therapy | Opportunistic Infections - microbiology | Opportunistic Infections - drug therapy | Enterobacteriaceae - drug effects | Anti-Bacterial Agents - pharmacology | Enterobacteriaceae Infections - drug therapy
Journal Article